Technology Partnership Between InterComponentWare AG (ICW) and Roche Diabetes Care Results in Launch of Overarching Web-based Solution

InterComponentWareICW technology sits in the center of the new online portal Accu-Chek® Connect which was recently introduced by Roche Diabetes Care. This new web-based solution empowers healthcare professionals and people living with diabetes to ease daily diabetes management. It enables seamless collaboration based on a central information view across blood glucose measurement devices, smartphone-apps, and offline solutions in current use.

ICW provided technology and development expertise into the technology partnership with Roche Diabetes Care, a global leader in diabetes management solutions. Jointly a next-generation system for effective and efficient self-management of individual diabetes therapies by people with diabetes was created, which allows to easily involve their healthcare professionals and caregivers into the process. The solution is built on top of a technology platform that facilitates the secure management of data as well as the shared use of that data between healthcare professionals and people with diabetes via the web. The solution also provides substantial reporting, intuitive graphics and easy-to-interpret visualization of relevant blood glucose and insulin data.

Regular and structured capture and evaluation of blood glucose and insulin data plays a pivotal part in effective diabetes management, but is usually challenging since multiple devices and data management approaches are used. Being able to consolidate all data in Roche Diabetes Care's shared Accu-Chek Connect platform ensures having the most reliable information base for their diabetes self-management to the person with diabetes. They can also use a simple and straightforward way of granting their healthcare professional access to all data relevant for making therapy decisions. This may result in greater adherence to recommendations and goals, and can lead to a better managed diabetes condition.

The online portal was built on top of the ICW eHealth Framework, which provides a modular, standards-oriented, and mature foundation for integration and secure management of sensitive personal health information. The ICW eHealth Framework enabled transferring measurement, medical and other diabetes related data from blood glucose measurement devices via PCs or smartphones to the web-based solution. Overlapping data streams are aggregated into a unique record, from which information required by the diabetes specialist or general practitioner for successful therapeutic intervention is derived. Managing this wealth of information on top of a framework that was built with personal health information security as an underlying design principle simplified adhering to different data privacy regulations across multiple target countries and provided corresponding auditability.

In partnership with Roche Diabetes Care, ICW configured and custom developed the aspects related to diabetes management and visualization. Scott Baxter, Head of Diabetes Management & Platform Solutions at Roche Diagnostics: "ICW's experience in state-of-the-art application design, information security and agile development significantly helped achieve the key goal of an intuitive and easy-to-use solution."

Related news articles:

About InterComponentWare AG
ICW is an international software company in the healthcare market, based in Walldorf, Germany. Our products and solutions support multiple stakeholders and integrate heterogeneous systems (connect), improve the efficiency of managing a patient through the care continuum (manage) and facilitate the engagement of patients in the treatment process (personalize). Our products are based on the latest technologies and standards, and support rapid development of eHealth solutions and flexible implementation of integrated care projects. Together with our partners, we deliver safe and sustainable eHealth solutions for more than 20 million patients and 10,000 providers.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...